25.10.2012 Views

Instructions for use: Ikus - Berlin Heart

Instructions for use: Ikus - Berlin Heart

Instructions for use: Ikus - Berlin Heart

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Antibiotic therapy<br />

Intensive care and aftercare<br />

9.2.1 Example: Platelet aggregation inhibition therapy - Adolescents/adults<br />

Platelet aggregation inhibition<br />

The required daily dose of the platelet aggregation inhibitor acetylsalicylic acid (Aspirin ® ,<br />

75 to 500 mg/d, p.o.) is divided into two daily doses (morning and evening) to<br />

counteract the strong thrombocyte neo<strong>for</strong>mation.<br />

Sufficient inhibition by Aspirin ® is achieved if, in the platelet aggregation test,<br />

arachidonic acid is reduced to < 30% and epinephrine to 40-50%.<br />

Platelet adhesion inhibition<br />

At a thrombocyte count of > 150,000/μl and/or higher amplitude in thromboelastography<br />

(> 80mm): Start of administration of the platelet adhesion inhibitor dipyridamol (150 to<br />

600 mg/d).<br />

9.2.2 Example: Platelet aggregation inhibition therapy - EXCOR Pediatric<br />

Platelet aggregation inhibition<br />

The required daily dose of the platelet aggregation inhibitor acetylsalicylic acid (Aspirin ® ,<br />

initial dose 1 mg/kg/d, p.o.) is divided into two daily doses (morning and evening) to<br />

counteract the strong thrombocyte neo<strong>for</strong>mation.<br />

Sufficient inhibition by Aspirin ® is achieved if, in the platelet aggregation test,<br />

arachidonic acid is reduced to < 30% and epinephrine to 40-50%.<br />

Platelet adhesion inhibition<br />

At a thrombocyte count of > 150,000/μl and/or higher amplitude in thromboelastography<br />

(> 80mm): Start of administration of the platelet adhesion inhibitor dipyridamol<br />

(4 mg/kg/d).<br />

9.3 Antibiotic therapy<br />

Recommendation<br />

• Per<strong>for</strong>m the therapy over 7 days.<br />

• A perioperative antibiotic prophylaxis with good staphylococcus coverage<br />

(e.g. cephalosporin, 2nd generation).<br />

• In the event of signs of local infection in the area of the transcutaneous passage or<br />

evidence of systemic infection: targeted antibiotic therapy after pathogen isolation in all<br />

accessible media (hemoculture, swab).<br />

• In the event of a cannula infection, per<strong>for</strong>m a long-term oral antibiotic therapy, beca<strong>use</strong><br />

otherwise repeated infection flareups may occur.<br />

9.4 Wound care<br />

The incision wound sites must be treated like open wounds. Wound care should be<br />

per<strong>for</strong>med in the inpatient area, and always by the same person. If the patient is<br />

discharged to outpatient care, the patient and family members must be instructed<br />

accordingly. The risk of infection can only be minimized by practicing careful wound care.<br />

Cautionary measure<br />

• For wound care, wear sterile disposable gloves, hood and face mask.<br />

Material (<strong>for</strong> biventricular access):<br />

• 1 pair of disposable gloves<br />

• 1 hood<br />

• 1 sterile face mask<br />

• 1 pair of sterile disposable gloves<br />

• 1 sterile drape (75x90 cm)<br />

• Disinfectant according to prescription<br />

• 8 sterile-packaged wound plasters (approx. 7x5 cm)<br />

56 1000002 Rev. 4.9.1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!